Pages that link to "Q47264373"
Jump to navigation
Jump to search
The following pages link to Jacques-Eric Gottenberg (Q47264373):
Displaying 50 items.
- miR-346 controls release of TNF-α protein and stability of its mRNA in rheumatoid arthritis via tristetraprolin stabilization (Q21135455) (← links)
- EULAR Sjögren's syndrome disease activity index (ESSDAI): a user guide (Q26778262) (← links)
- Inhibition of clinical benefits of aspirin on first myocardial infarction by nonsteroidal antiinflammatory drugs (Q28167625) (← links)
- International and multidisciplinary expert recommendations for the use of biologics in systemic lupus erythematosus (Q30234696) (← links)
- Development of the Sjögren's Syndrome Responder Index, a data-driven composite endpoint for assessing treatment efficacy (Q30948155) (← links)
- Increased Dickkopf-1 in Recent-onset Rheumatoid Arthritis is a New Biomarker of Structural Severity. Data from the ESPOIR Cohort (Q31038073) (← links)
- Epidemiology of neurological manifestations in Sjögren's syndrome: data from the French ASSESS Cohort (Q31083973) (← links)
- Influence of geolocation and ethnicity on the phenotypic expression of primary Sjögren's syndrome at diagnosis in 8310 patients: a cross-sectional study from the Big Data Sjögren Project Consortium (Q31145428) (← links)
- Safety of surgery in patients with rheumatoid arthritis treated by abatacept: data from the French Orencia in Rheumatoid Arthritis Registry (Q31152756) (← links)
- In primary Sjögren's syndrome, HLA class II is associated exclusively with autoantibody production and spreading of the autoimmune response (Q33349381) (← links)
- Tolerance and efficacy of rituximab and changes in serum B cell biomarkers in patients with systemic complications of primary Sjögren's syndrome (Q33372523) (← links)
- Registries in rheumatoid arthritis and autoimmune diseases: data from the French registries (Q33767771) (← links)
- EULAR Sjogren's syndrome disease activity index: development of a consensus systemic disease activity index for primary Sjogren's syndrome (Q34117422) (← links)
- Incidence of new-onset and flare of preexisting psoriasis during rituximab therapy for rheumatoid arthritis: data from the French AIR registry (Q34233372) (← links)
- Rituximab treatment for spondyloarthritis. A nationwide series: data from the AIR registry of the French Society of Rheumatology (Q34381180) (← links)
- MiR-30a-3p negatively regulates BAFF synthesis in systemic sclerosis and rheumatoid arthritis fibroblasts (Q34434727) (← links)
- Activation of IFN pathways and plasmacytoid dendritic cell recruitment in target organs of primary Sjögren's syndrome (Q34479625) (← links)
- NCR3/NKp30 contributes to pathogenesis in primary Sjogren's syndrome (Q34541173) (← links)
- Effects of hydroxychloroquine on symptomatic improvement in primary Sjögren syndrome: the JOQUER randomized clinical trial (Q34663199) (← links)
- Serum levels of beta2-microglobulin and free light chains of immunoglobulins are associated with systemic disease activity in primary Sjögren's syndrome. Data at enrollment in the prospective ASSESS cohort (Q34743817) (← links)
- No evidence for an association between the -871 T/C promoter polymorphism in the B-cell-activating factor gene and primary Sjögren's syndrome (Q34896464) (← links)
- Bruton's tyrosine kinase is involved in miR-346-related regulation of IL-18 release by lipopolysaccharide-activated rheumatoid fibroblast-like synoviocytes (Q34973908) (← links)
- Which and How Many Patients Should Be Included in Randomised Controlled Trials to Demonstrate the Efficacy of Biologics in Primary Sjögren's Syndrome? (Q35774612) (← links)
- Increase of B cell-activating factor of the TNF family (BAFF) after rituximab treatment: insights into a new regulating system of BAFF production (Q35953204) (← links)
- Decreased B cell activating factor receptor expression on peripheral lymphocytes associated with increased disease activity in primary Sjögren's syndrome and systemic lupus erythematosus (Q35953373) (← links)
- Abatacept monotherapy compared with abatacept plus disease-modifying anti-rheumatic drugs in rheumatoid arthritis patients: data from the ORA registry (Q35974381) (← links)
- Outcome of hepatitis E virus infection in patients with inflammatory arthritides treated with immunosuppressants: a French retrospective multicenter study (Q36009254) (← links)
- Severe Health-Related Quality of Life Impairment in Active Primary Sjögren's Syndrome and Patient-Reported Outcomes: Data From a Large Therapeutic Trial (Q36070691) (← links)
- Sjogren's syndrome is associated with and not secondary to systemic sclerosis (Q36551164) (← links)
- Dendritic cells and interferon-mediated autoimmunity (Q36846871) (← links)
- Klinefelter's syndrome (47,XXY) is in excess among men with Sjögren's syndrome (Q37083442) (← links)
- Rituximab: a new therapeutic alternative in rheumatoid arthritis (Q37197613) (← links)
- Microparticle-induced release of B-lymphocyte regulators by rheumatoid synoviocytes (Q37206923) (← links)
- Cognitive Dysfunction and Dementia in Primary Sjögren's Syndrome (Q37221887) (← links)
- X Chromosome Dose and Sex Bias in Autoimmune Diseases: Increased Prevalence of 47,XXX in Systemic Lupus Erythematosus and Sjögren's Syndrome (Q37249179) (← links)
- Markers of B-lymphocyte activation are elevated in patients with early rheumatoid arthritis and correlated with disease activity in the ESPOIR cohort (Q37350904) (← links)
- Idiosyncratic Drug-Induced Severe Neutropenia and Agranulocytosis in Elderly Patients (≥75 years): A Monocentric Cohort Study of 61 Cases (Q37452801) (← links)
- Increased levels of circulating microparticles in primary Sjögren's syndrome, systemic lupus erythematosus and rheumatoid arthritis and relation with disease activity (Q37454013) (← links)
- Abatacept therapy and safety management (Q37533319) (← links)
- Risk of invasive melanoma in patients with rheumatoid arthritis treated with biologics: results from a collaborative project of 11 European biologic registers (Q37616987) (← links)
- Targeting the splicing of mRNA in autoimmune diseases: BAFF inhibition in Sjögren's syndrome as a proof of concept (Q37696041) (← links)
- Tumor necrosis factor-alpha blockers in SAPHO syndrome (Q37753587) (← links)
- Tocilizumab: therapy and safety management (Q37770789) (← links)
- Pathogenesis of Sjögren's syndrome and therapeutic consequences (Q37776624) (← links)
- EULAR Sjogren's Syndrome Patient Reported Index (ESSPRI): development of a consensus patient index for primary Sjogren's syndrome (Q37846349) (← links)
- Safety and efficacy of anti-tumor necrosis factor α therapy in ten patients with recent-onset refractory reactive arthritis (Q37850935) (← links)
- Primary Sjögren's syndrome: time for prospective cohorts (Q37972342) (← links)
- Outcome measures for primary Sjögren's syndrome (Q37988207) (← links)
- Management of secondary immune deficiencies: what is the role of immunoglobulins? (Q38123101) (← links)
- Outcome measures for primary Sjögren's syndrome: a comprehensive review (Q38177429) (← links)